Quantum Cyber N.V. Basic Shares Outstanding (Weighted Average)
Quantum Cyber N.V. (QUCY) reported Basic Shares Outstanding (Weighted Average) of 17.85 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Quantum Cyber N.V. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 17.85M shares, a 308.53% increase year-over-year.
- Quantum Cyber N.V. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 11.80M shares, a 243.92% increase year-over-year.
- Quantum Cyber N.V. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 4.37M shares.
- Quantum Cyber N.V. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 3.43M shares.
- Quantum Cyber N.V. weighted average number of shares outstanding, basic for fiscal 2025 was 6.00M shares, a 508.38% increase from fiscal 2024.
- Quantum Cyber N.V. weighted average number of shares outstanding, basic for fiscal 2024 was 985.72K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|
| 2026-06-30 | 17.85M shares 10-Q · filed 2026-08-14 | 14.84M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 11.80M shares 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | 6.00M shares 10-K · filed 2026-03-31 | ||
| 2025-06-30 | 4.37M shares 10-Q · filed 2026-08-14 | 3.90M shares 10-Q · filed 2026-08-14 | |
| 2025-03-31 | 3.43M shares 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | 985.72K shares 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |